Universitätsklinikum Essen

Tolerability of BRAF/MEK inhibitor combinations: Adverse event evaluation and management (2019) Heinzerling L, Eigentler TK, Fluck M, Hassel JC, Heller-Schenck D, Leipe J, Pauschinger M, et al. Journal article, Review article Adverse events 2.0-Let us get SERIOs New reporting for adverse event outcomes needed in the era of immunooncology (2019) Heinzerling L, Ascierto PA, Dummer R, Gogas H, Grob JJ, Lebbe C, Long GV, et al. Journal article, Letter Comparing artificial intelligence algorithms to 157 German dermatologists: the melanoma classification benchmark (2019) Brinker TJ, Hekler A, Hauschild A, Berking C, Schilling B, Enk AH, Haferkamp S, et al. Journal article Algorithm Deviates From the Guideline Reply (2019) Bolenz C, Schroeppel B, Eisenhardt A, Schmitz-Draeger BJ, Grimm MO Journal article, Letter Biomarker results from a phase II study of MEK1/2 inhibitor binimetinib (MEK162) in patients with advanced NRAS- or BRAF-mutated melanoma (2019) Van Herpen CM, Agarwala SS, Hauschild A, Berking C, Thaddeus Beck J, Schadendorf D, Jansen R, et al. Journal article Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution (2019) Masuda T, Sankowski R, Staszewski O, Boettcher C, Amann L, Scheiwe C, Nessler S, et al. Journal article Octreotide SC depot in patients with acromegaly and functioning neuroendocrine tumors: a phase 2, multicenter study (2019) Pavel ME, Borson-Chazot F, Cailleux A, Hoersch D, Lahner H, Pivonello R, Tauchmanova L, et al. Journal article Autophagic degradation of lamins facilitates the nuclear egress of herpes simplex virus type 1 (2019) Turan A, Grosche L, Krawczyk A, Mühl-Zürbes P, Drassner C, Düthorn A, Kummer M, et al. Journal article Imaging flow cytometry facilitates multiparametric characterization of extracellular vesicles in malignant brain tumours (2019) Ricklefs FL, Maire CL, Reimer R, Dührsen L, Kolbe K, Holz M, Schneider E, et al. Journal article Sources of information and support for melanoma patients: differences between patients’ and clinicians’ preferences Informations- und Hilfsangebote für Melanompatienten: Präferenzielle Unterschiede zwischen Patienten und Ärzten (2019) Brütting J, Bergmann M, Schadendorf D, Weber C, Tilgen W, Berking C, Meier F, Nvkh iAd Journal article